-
The role of statins in heart failure patients is poorly studied and controversial. Thus, Khush and colleagues analyzed the secondary endpoint in the Treating to New Targets (TNT) study of hospitalization for heart failure.
-
The Food and Drug Administration (FDA) cautions about increased risks of adverse events with the combination of statins and niacin, yet achieving current lipid treatment targets often requires multiple drug therapy.
-
A longstanding controversy exists regarding the importance of a patent foramen ovale (PFO) as a cause for TIA or stroke.
-
Despite their advantages in preventing restenosis, drug-eluting stents (DES) have recently been found to be at risk for late stent thrombosis.
-
Greenfield RH. Oh, to B12 again ... Metformin use and B12 deficiency. Altern Med Alert 2007;10(4):46-47. Greenfield RH. Living with syn: Synbiotics and colon cancer. Altern Med Alert 2007;10(4):47-48. Greenfield RH. Pressure and pain—Analgesic use and blood pressure. Altern Med Alert 2007;10(4):48.
-
Sindwani T. Pelargonium sidoides for treatment of acute bronchitis. Altern Med Alert 2007;10(4):43-45.
-
Antibiotics, also known as antimicrobial drugs, are drugs that fight infections caused by bacteria.
-
McKay D. Vitamin E supplementation: An update. Altern Med Alert 2007;10(4):37-42.
-
This paper describes results from a multi-center registry located at the Minneapolis Heart Institute Foundation that collects data on device failure in pacemakers and implantable defibrillators.
-